Evidence map›Paper›PMID 29237458›Full record

ArticleBMC veterinary research2017

Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines.

Corri B Levine, Julie Bayle, Vincent Biourge, Joseph J Wakshlag

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Frontiers in oncology · 2026
    Article
  4. Anti-Cancer Activity ofMarine drugs · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Cytotoxic Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Corri B LevineDepartment of Clinical Sciences,Veterinary Medical Center C2-009, Cornell University College of Veterinary Medicine, Ithaca, NY, 14853, USA.
Julie BayleRoyal Canin Research Center, Airmargues, France.
Vincent BiourgeRoyal Canin Research Center, Airmargues, France.
Joseph J WakshlagDepartment of Clinical Sciences,Veterinary Medical Center C2-009, Cornell University College of Veterinary Medicine, Ithaca, NY, 14853, USA. jw37@cornell.edu.
Cornell University · USNew York State College of Veterinary Medicine · US

Funding

Royal Canin NA
6 · The paper itself

Abstract

backgroundThe use of nutraceuticals is gaining in popularity in human and canine oncology with a relatively limited understanding of the effects in the vastly different tumor types seen in canine oncology. We have previously shown that turmeric root (TE) and rosemary leaf (RE) extracts can work synergistically to reduce neoplastic cell growth, but the mechanisms are poorly understood and require further elucidation.

resultsThree different canine cell lines (C2 mastocytoma, and CMT-12 mammary carcinoma, D17 osteosarcoma) were treated with 6.3 μg mL

conclusionsThe use of RE in combination with TE induces a synergistic response to induce apoptosis which is better than either extract alone. This appears to be related to a variable increased TE uptake in cells and activation of pathways involved in the apoptotic response.

Indexed as

Plant LeavesRosmarinusAnimalsBone NeoplasmsCell Line, TumorCurcumaDog DiseasesDogsFemaleMammary Neoplasms, AnimalMastocytomaOsteosarcomaPhytotherapyPlant ExtractsPlant Extractsturmeric extractApoptosisCanine cancerCurcuminMammary carcinomaMastocytomaOsteosarcomaRosemary

Identifiers

PMID29237458
PMCPMC5729263
OpenAlexW2775239314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.